News

Close-up of the arms of scientist in white lab coat wearing blue gloves and holding an injection device.

Moderna's mRNA vaccines take on cancer

New York Times

Moderna, co-founded by Bob Langer, announced that late-stage trials showed its mRNA cancer vaccine reduced the ​risk of melanoma recurrence and spread when used in conjunction with an immunotherapy called pembrolizumab—the first positive results for mRNA cancer vaccines and for combination therapies with pembrolizumab. Moderna is testing similar approaches against lung, breast, and pancreatic cancers with its partners.

New York Times | Washington Post | STAT | CNBC

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Levine behind the scenes

MIT News

Stuart Levine co-leads the Robert A. Swanson (1969) Biotechnology Center’s Integrated Genomics and Bioinformatics core facility, bringing PhD-level education, expansive scientific and technological expertise, and hands on training opportunities to the table in support of researchers across more than 100 labs annually at the Koch Institute and MIT.

Levine and his team work with cutting-edge, finely tuned scientific instruments that generate vast amounts of bioinformatics data, and then use powerful computational tools to store, organize, and visualize the data collected, contributing to research on topics in cancer and beyond, from host-parasite interactions to proposed tools for NASA’s planetary protection policy.

An upgrade for glioblastoma therapy

MIT Koch Institute

New nanoparticles from the Hammond and Straehla groups bolster a technique for delivering therapeutics to brain tissues and improve treatment for glioblastoma. Combined with localized, convection-enhanced delivery, their nanoparticle designimproved targeting, distribution and retention of nanoparticles andtherapeutics within the tumor. In a Journal of the American Chemical Society study, the approach strongly outperformed both free drug and another version of the drug to significantly extend survival.

Dual duty microneedles

Nature Materials

A new Jaklenec lab study published in Nature Materials demonstrates novel microneedle patches that can be applied to the skin to deliver mRNA drugs and store billions of bits of anonymous and reliable information. This technology could be used to enhance healthcare in low resource settings, while addressing critical challenges related to  reliability and privacy of traditional paper and digital database systems for patient information.

Changing the math on drug delivery

MIT Koch Institute

Louis DeRidder, a graduate student in the Langer and Traverso groups, details his journey to a career in biomedical research. Inspired by a childhood medical emergency and a high school shadowing program, he is now a driving force in a Bridge Project team developing CLAUDIA, a closed-loop drug delivery system designed to tailor doses of chemotherapy to individual patients for maximum safety and effectiveness.

Science on the menu

MIT News

MIT hosted its annual “Breakfast with Scientists,” where some of the nation’s most talented high school researchers met with with leading scientific minds, including KI faculty members Amy Keating, Kristen Knouse, and Phillip Sharp. Student delegates were convened in Boston for the American Junior Academy of Science conference, held alongside the American Association for the Advancement of Science annual meeting.

Balancing game for brain cancer treatment

Eureka Alert

A collaborative study creates a detailed picture of immune programs in important brain tumor cells and how their relative expression can predict immunotherapy response and overall survival. The study, published in Nature and supported by the Ludwig Centers of MIT and Harvard, and McGill University, showed that dexamethasone, commonly prescribed to brain cancer patients to reduce swelling, suppresses the immune system for weeks after administration and can inhibit immune activity and immunotherapy response.

Tardi-grade A science

MIT News

About 60 percent of cancer patients in the U.S. receive radiation therapy, which can have severe side effects. In a study published in Nature Biomedical Engineering, a team led by Giovanni Traverso discovered that a protein from tardigrades (microscopic "water bears") can protect human cells from radiation damage, minimizing treatment side effects.

Solving the puzzle of immune evasion

MIT News

Stefani Spranger’s work is focused on uncovering why some tumors evade the immune system’s attack. For example, her latest research, published in Cancer Immunology Research, reveals that lung cancer cells expressing SOX2 can block CD8+ T cells, undermining checkpoint blockade therapy. “By understanding these resistance mechanisms, we can develop smarter immunotherapies to outmaneuver cancer,” says Spranger.

AI in Action 

Forbes

Assessing promise versus prudence for AI in healthcare, Forbes highlighted Regina Barzilay's research showing AI can reliably improve breast cancer detection rates by 20% without increasing false positives. In a recent interview with Cancer Network, Barzilay discussed how AI’s proven ability to improve cancer detection rates in both breast and lung cancer screening may eventually push for updates to outdated protocols.

Koehler to lead MIT HEALS

MIT Office of the President

Congratulations to Angela Koehler on being named director of the MIT Health and Life Sciences Collaborative (MIT HEALS). MIT HEALS was established last year to bring together researchers from across the Institute to innovate new solutions to urgent challenges in health care. Koehler will be joined by two associate directors: Department of Biology professor Iain Cheeseman and Department of Biological Engineering professor Katharina Ribbeck.